CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 28  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0834
LYS 10.0637
GLU 20.0461
LEU 30.0253
ARG 40.0217
CYS 50.0183
GLN 60.0049
CYS 70.0161
ILE 80.0184
LYS 90.0220
THR 100.0165
TYR 110.0102
SER 120.0129
LYS 130.0145
PRO 140.0075
PHE 150.0103
HIS 160.0299
PRO 170.0102
LYS 180.0191
PHE 190.0093
ILE 200.0063
LYS 210.0036
GLU 220.0096
LEU 230.0149
ARG 240.0154
VAL 250.0160
ILE 260.0126
GLU 270.0144
SER 280.0151
GLY 290.0288
PRO 300.0612
HIS 310.0384
CYS 320.0265
ALA 330.0268
ASN 340.0184
THR 350.0138
GLU 360.0129
ILE 370.0167
ILE 380.0131
VAL 390.0113
LYS 400.0070
LEU 410.0069
SER 420.0118
ASP 430.0297
GLY 440.0209
ARG 450.0223
GLU 460.0082
LEU 470.0119
CYS 480.0120
LEU 490.0137
ASP 500.0218
PRO 510.0167
LYS 520.0289
GLU 530.0256
ASN 540.0285
TRP 550.0181
VAL 560.0055
GLN 570.0108
ARG 580.0191
VAL 590.0149
VAL 600.0164
GLU 610.0325
LYS 620.0232
PHE 630.0151
LEU 640.0220
LYS 650.0046
ARG 660.0139
ALA 670.0196
GLU 680.0415
ASN 690.0834

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.